N. Reynaert (Maastricht, Netherlands), K. Belchamber (Birmingham, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
J. Baker (London, United Kingdom), P. Fenwick (London, United Kingdom), H. Owles (London, United Kingdom), C. Koss (Biberach an der Riß, Germany), K. El-Kasmi (Biberach an der Riß, Germany), P. Barnes (London, United Kingdom), L. Donnelly (London, United Kingdom)
|   |
Effect of allergen-activated eosinophils on contractility and migration of ASMC and PF in asthma
I. Janulaityte (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), E. Jurkeviciute (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), B. Tamasauskaite (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
Increased cough, mucus and wheeze characterise COPD and Asthma in Australian Aboriginal adults
N. Young (Newcastle, Australia), W. Chen (Newcastle, Australia), D. Wong (Newcastle, Australia), S. Chatterjee (Newcastle, Australia), A. Lam'Aan Latheef (Newcastle, Australia), J. Simpson (Newcastle, Australia), P. Wark (Newcastle, Australia), A. Cook (Newcastle, Australia)
| |
T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients
I. Kwiecien (Warszawa, Poland), E. Rutkowska (Warszawa, Poland), J. Bednarek (Warszawa, Poland), R. Sokolowski (Warszawa, Poland), K. Jahnz- Rózyk (Warszawa, Poland), J. Domagala-Kulawik (Warszawa, Poland), P. Rrzepecki (Warszawa, Poland)
| |
Destructive-cytolytic and peroxidase activity of bronchial granulocytes in asthma patients with different levels of disease control
J. Perelman (Blagoveshchensk (Amur Oblast), Russian Federation), A. Pirogov (Blagoveshchensk (Amur Oblast), Russian Federation), A. Prikhodko (Blagoveshchensk (Amur Oblast), Russian Federation)
| |
Profiling of COPD and IPF cytokine responses in human lung
D. Thakker (Nottingham, United Kingdom), A. Henry (Nottingham, United Kingdom), C. K. Billington (Nottingham, United Kingdom), B. Kc (Nottingham, United Kingdom), T. Rimington (Nottingham, United Kingdom), I. Sayers (Nottingham, United Kingdom), I. Hall (Nottingham, United Kingdom)
| |
Normal values for bronchoalveolar lavage (BAL) differential cell count and lymphocyte subpopulations
D. Soriano (Freiburg, Germany), S. Fähndrich (Freiburg, Germany), T. Köhler (Freiburg, Germany), W. Meschede (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany), G. Zissel (Freiburg, Germany), B. Frye (Freiburg, Germany)
| |
The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD
A. Kadushkin (Minsk, Belarus), A. Tahanovich (Minsk, Belarus), ?. Kolesnikova (Minsk, Belarus), E. Hodosovskaya (Minsk, Belarus), E. Talabayeva (Minsk, Belarus), A. Plastinina (Minsk, Belarus)
| |
Recruitment of Dendritic Cells by Factor XIII (FXIII) facilitates the immune response in COPD
A. Casara (Padova (PD), Italy), E. Bazzan (Padova (PD), Italy), U. Semenzato (Padova (PD), Italy), M. Tinè (Padova (PD), Italy), M. Bonato (Padova (PD), Italy), E. Cocconcelli (Padova (PD), Italy), G. Turato (Padova (PD), Italy), S. Baraldo (Padova (PD), Italy), C. Radu (Padova (PD), Italy), P. Simioni (Padova (PD), Italy), M. Cosio (Montreal , Canada), M. Saetta (Padova (PD), Italy)
| |
Theophylline and budesonide downregulate production of cytokines by blood T lymphocytes of patients with COPD
A. Kadushkin (Minsk, Belarus), A. Tahanovich (Minsk, Belarus), V. Dziadzichkina (Minsk, Belarus), L. Movchan (Minsk, Belarus), T. Shman (Minsk, Belarus)
| |
Differential response of monocyte-derived macrophages from COPD and healthy subjects to LPS/IFN? stimulation
D. Naumov (Blagoveshchensk (Amur Oblast), Russian Federation), I. Sugaylo (Blagoveshchensk (Amur Oblast), Russian Federation), D. Gassan (Blagoveshchensk (Amur Oblast), Russian Federation), O. Kotova (Blagoveshchensk (Amur Oblast), Russian Federation), E. Afanaseva (Blagoveshchensk (Amur Oblast), Russian Federation), E. Sheludko (Blagoveshchensk (Amur Oblast), Russian Federation), Y. Gorchakova (Blagoveshchensk (Amur Oblast), Russian Federation)
| |
Neutrophil to lymphocyte ratio and severity of COPD : prospective study
I. Touil (MAHDIA, Tunisia), H. BAILI (MAHDIA, Tunisia), Y. Brahem (MAHDIA, Tunisia), S. Bouchareb (MAHDIA, Tunisia), N. Keskes Boudawra (MAHDIA, Tunisia), S. Kessisa (MAHDIA, Tunisia), J. Ayeb (MAHDIA, Tunisia), J. Knani (MAHDIA, Tunisia), L. Boussoffara (MAHDIA, Tunisia)
| |
Analysis of DNA repair synthesis in peripheral blood lymphocytes from patients with well-controlled and uncontrolled asthma
A. Lintsov (St.Petersburg, Russian Federation), A. Soliev (St.Petersburg, Russian Federation), P. Slizhov (St.Petersburg, Russian Federation), N. Pleskach (St.Petersburg, Russian Federation), V. Mikhelson (St.Petersburg, Russian Federation)
| |
Transcriptome profiling of platelets from patients with severe asthma.
M. Chebbo (Marseille, France), S. Assou (Montpellier, France), V. Pantesco (Montpellier, France), C. Duez (Marseille, France), A. Bourdin (Montpellier, France), P. Chanez (Marseille, France), D. Gras (Marseille, France)
| |
Cytokine production of alveolar macrophages is decreased by OR2AT4
D. Weidinger (Bochum, Germany), K. Jamal Jameel (Bochum, Germany), D. Alisch (Bochum, Germany), M. Ruhe (Bochum, Germany), P. Bürger (Bochum, Germany), S. Rohde (Bochum, Germany), F. Yusuf (Bochum, Germany), P. Kaufmann (Bochum, Germany), J. Kronsbein (Bochum, Germany), M. Peters (Bochum, Germany), N. Giannakis (Bochum, Germany), H. Hatt (Bochum, Germany), J. Knobloch (Bochum, Germany)
| |
Deconvolution of the sputum transcriptome and methylome by quadratic programming in asthma and COPD
E. Groth (Großhansdorf, Germany), M. Weber (Princeton, United States of America), T. Bahmer (Kiel, Germany), F. Pedersen (Großhansdorf, Germany), A. Kirsten (Großhansdorf, Germany), D. Börnigen (Hamburg, Germany), K. Rabe (Großhansdorf, Germany), H. Watz (Großhansdorf, Germany), O. Ammerpohl (Ulm, Germany), T. Goldmann (Borstel, Germany)
| |
In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients
A. Januskevicius (Kaunas, Lithuania), E. Jurkeviciute (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), B. Tamasauskaite (Kaunas, Lithuania), I. Janulaityte (Kaunas, Lithuania), V. Kalinauskaite-Zukauske (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
The bronchial challenge with D. pteronyssinus enhanced pro-proliferative properties of inflammatory eosinophils subtype in allergic asthma patients
E. Jurkeviciute (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), B. Tamasauskaite (Kaunas, Lithuania), I. Janulaityte (Kaunas, Lithuania), V. Kalinauskaite-Zukauske (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
Gender-specific differences in leukocyte subsets of end-stage COPD patients analyzed by flow cytometry
A. Cho (Vienna, Austria), A. Benazzo (Vienna, Austria), J. Mucha (Vienna, Austria), A. Weijler (Vienna, Austria), U. Just (Vienna, Austria), R. Knobler (Vienna, Austria), K. Hoetzenecker (Vienna, Austria), T. Wekerle (Vienna, Austria), P. Jaksch (Vienna, Austria)
| |